Churg-Strauss and montelukast

Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):1079-82. doi: 10.1177/039463201102400426.

Abstract

Churg-Strauss syndrome (CSS) is a systemic small vessel vasculitis involving lungs, skin, heart, gastrointestinal tract and peripheral nerves. We report the case of a 36-year-old woman with a necrotic lesion on the left foot of two months duration, associated with hypereosinophilia, patchy lung infiltrates, cardiac damage and a mononeuritis. The personal history was remarkable only for an asthma, treated with Montelukast, a leukotriene receptor antagonist (LRA). Clinical symptoms, laboratory exams and instrumental examinations led us to the diagnosis of CSS. In recent years several studies have reported the possible relationship between use of leukotriene receptor antagonist (LRA) and CSS expression. We report this case to underline the possible relationship between LRA and CSS and its etiopathogenetic mechanism.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetates / adverse effects*
  • Adult
  • Anti-Asthmatic Agents / adverse effects*
  • Asthma / drug therapy*
  • Churg-Strauss Syndrome / chemically induced*
  • Churg-Strauss Syndrome / diagnosis
  • Cyclopropanes
  • Female
  • Humans
  • Leukotriene Antagonists / adverse effects*
  • Quinolines / adverse effects*
  • Sulfides

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • montelukast